Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 1/2 1

Status

Completed 2Terminated 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Lymphoid 1Gastrointestinal 1Breast 1

Conditions

Sarcoma 1Neoplasms 1Neoplasm Metastasis 1Lymphoma 1Colonic Neoplasms 1Cholangiocarcinoma 1Breast Neoplasms 1Advanced Solid Tumor 1

Interventions

pembrolizumab 305Paclitaxel 205Carboplatin 201Gemcitabine 173Cisplatin 140Docetaxel 138Cyclophosphamide 137Nivolumab 129Bevacizumab 118Injections 112fludarabine 97atezolizumab 91Pemetrexed 91Dexamethasone 90Cetuximab 90Fluorouracil 84Irinotecan 77Rituximab 72Capecitabine 72venetoclax 71Azacitidine 70130-nm albumin-bound paclitaxel 67Leucovorin 65Fulvestrant 58Oxaliplatin 57durvalumab 56Trastuzumab 56Midazolam 55Lenalidomide 55Ipilimumab 55

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × INDUSTRY × crenigacestat × Clear all
NCT01695005 2025-12-26

A Study of LY3039478 in Participants With Advanced Cancer

Eli Lilly and Company

Phase 1 Completed
247 enrolled 53 charts
Lymphoid

Lymphoma, Neoplasm Metastasis, Neoplasms

NCT02784795 2025-08-21

A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors

Eli Lilly and Company

Phase 1 Terminated
94 enrolled 28 charts
BreastGastrointestinalSarcoma

Breast Neoplasms, Colonic Neoplasms, Sarcoma, Cholangiocarcinoma

NCT02836600 2025-08-07

A Study of LY3039478 in Japanese Participants With Advanced Solid Tumors

Eli Lilly and Company

Phase 1 Completed
11 enrolled 9 charts
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡